The Fund Grade · free · no account needed
What grade does XCAPX get?
Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.
Fundprints Fund Grade · as of 2026-10-01
ACAP Strategic Fund
#151 of 500 graded active funds · blend · large segment peer group
The point · specialist footprint
XCAPX puts more of its book behind proven specialists than 78% of graded funds.
Bottom 20%
Bottom 40%
Middle
● Top 40%
Top 20%
That has mattered: over the past 2.7 years, funds on this rung beat bottom-rung funds by about 3.8% per quarter, and beat the S&P in 43% of fund-quarters versus their 22%. The evidence argues this fund earns its seat.
10,000+ funds tracked · the graded specialists among them drive every read
The grade scores this fund's specialist share, the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.
XCAPX vs the Honor Roll · share card ↗Conviction exposure
43.5%
of the book in specialist-converged names
Late-stage weight
21.3%
of the book in Crowded or Fading names
Active share
90%
how far it strays from the index
The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.
Inside the book: top names by stage · as of 2026-10-20
We email you the day it crosses 50% crowded, and where you stand every month.
Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.
The read · what to do with it
ACAP Strategic Fund earns a B grade and ranks 151 of 500, with specialists making up 43.5% of its ownership. The early story here is AMZN, META, and LRCX, all at Early Conviction stage, while VRT, APH, and MLM are positions where specialists are actively walking away.
→ Watch VRT, APH, and MLM closely, as specialist exits from all three suggest these positions may face pressure.
→ The Early Conviction readings on AMZN, META, and LRCX argue this fund is genuinely ahead of the crowd on those three names.
Support leaving these positions
Read from today's disclosed book. Evidence, not advice.